Stock Updates

Performance Details for: Novo Nordisk A/S (NYSE:NVO)

The company in question is, Novo Nordisk A/S (NYSE:NVO) currently with a stock price of 42.84 (0.59% today). The market cap for Novo Nordisk A/S is 83.43 B, and is in the sector Healthcare, and Drug Manufacturers РOther industry. The target price for Novo Nordisk A/S is 36.7. Currently Novo Nordisk A/S is trading with a P/E of 18.37, and a forward P/E of 17.04. Average volume for Novo Nordisk A/S is 2293.91 and so far today it is 65550.

Performance in the last year for Novo Nordisk A/S has been -17.86%. For EPS growth, Novo Nordisk A/S has seen a growth of 10.60%, and is looking to grow in the next year to 10.67%. More long term stats show that EPS growth has been 20.10% over the last five years and could be 9.50% for the next five years. Novo Nordisk A/S has seen sales growth quarter over quarter at 4.60%, with EPS growth quarter over quarter at 9.60%. The 20-day simple moving average is 0.79%, with the 200-day simple moving average coming to 13.50%.

Since the IPO date for Novo Nordisk A/S on the 01/04/1982, Novo Nordisk A/S has seen performance year to date to be 18.77%. With Novo Nordisk A/S trading at 42.84, the dividend yield is 2.63%, and the EPS is 2.32.

So could Novo Nordisk A/S, be undervalued? Well as said before P/E is 18.37. The PEG is 1.93, P/S is 4.88 and the P/B is at 17.45. The P/cash is 31.02, with P/free cash flow at 22.

Novo Nordisk A/S ability to deal with debt shows that the current ratio is 1.1, and the quick ratio is 0.8. This is with long term debt/equity at 0, and total debt/equity at 0.02.

In terms of margins, Novo Nordisk A/S has a gross margin of 84.80%, an operating margin of 43.90% and a profit margin of 34.20%.Payout ratio for Novo Nordisk A/S is 44.10%. Return on assets come to 42.10% with return on investment coming to 84.70%.

Insider ownership for Novo Nordisk A/S, is at 26.40% and institutional ownership comes to 8.50%. Outstanding shares are at 1958.95. While shares float is 1304.81. The float short is currently 0.33%, and short ratio is 1.85.

Graphs: Novo Nordisk A/S NYSE: NVO | Friday June 16, 2017


Novo Nordisk A/S NYSE: NVO




Novo Nordisk A/S NYSE: NVO

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Mark Hines

Leave a Comment